Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use: the SHARPS study

Table 4 Self-reported substance use at baseline and follow-up

Substance	Baseline whole cohort	Baseline for both measures cohort	Follow-up
Substance	N = 44*	N = 30	N = 30
Alcohol n (%)	21 (48)	16 (53)	15 (50)
Days	12 [2, 30]	19 [2, 30]	5 [1, 30]
Heroin n (%)	22 (50)	15 (50)	9 (30)
Inject	9	5	6
Smoke	13	10	3
Days	13 [2, 30]	6 [1, 30]	2 [1, 3]
Cocaine (crack) n (%)	23 (52)	15 (50)	11 (37)
Inject	17	12	8
Smoke	5	2	2
Days	13 [2, 30]	11 [1, 21]	2 [1, 8]
Opioids n (%)	25 (57)	17 (57)	23 (77)
Oral	22	14	22
Sniff			1
Days	30 [30, 30]	30 [30, 30]	30 [30, 30]
Benzos n (%)	13 (30)	9 (30)	7 (23)
Days	30 [4, 30]	30 [4, 30]	30 [4, 30]
Gabapentinoids n (%)	15 (34)	11 (37)	7 (23)
Oral	14	9	6
Snort/sniff	1	1	1
Days	3 [2, 30]	10 [2, 30]	2 [2, 30]
Cannabis	19 (43)	13 (43)	13 (43)
Smoke	19	13	13
Days	15 [2, 27]	15 [14, 30]	30 [30, 30]

Cells are n and (%) except for rows with days which summarises median [25th, 75th centile] days of use. *One participant who completed the baseline measures did not complete the full suite of measures (2/6 completed), hence 44 rather than 45. This participant did not complete follow-up measures as they completed the shortened intervention

ISSN: 1477-7517